Show simple item record

dc.contributor.authorGuerin, P J
dc.contributor.authorOlliaro, P
dc.contributor.authorNosten, F
dc.contributor.authorDruilhe, P
dc.contributor.authorLaxminarayan, R
dc.contributor.authorBinka, F
dc.contributor.authorKilama, W L
dc.contributor.authorFord, N
dc.contributor.authorWhite, N J
dc.date.accessioned2008-09-05T09:13:33Z
dc.date.available2008-09-05T09:13:33Z
dc.date.issued2002-09
dc.identifier.citationMalaria: current status of control, diagnosis, treatment, and a proposed agenda for research and development. 2002, 2 (9):564-73notLancet Infect Disen
dc.identifier.issn1473-3099
dc.identifier.pmid12206972
dc.identifier.urihttp://hdl.handle.net/10144/37314
dc.description.abstractRolling back malaria is possible. Tools are available but they are not used. Several countries deploy, as their national malaria control treatment policy, drugs that are no longer effective. New and innovative methods of vector control, diagnosis, and treatment should be developed, and work towards development of new drugs and a vaccine should receive much greater support. But the pressing need, in the face of increasing global mortality and general lack of progress in malaria control, is research into the best methods of deploying and using existing approaches, particularly insecticide-treated mosquito nets, rapid methods of diagnosis, and artemisinin-based combination treatments. Evidence on these approaches should provide national governments and international donors with the cost-benefit information that would justify much-needed increases in global support for appropriate and effective malaria control.
dc.language.isoenen
dc.rightsPublished by Elsevier Reproduced on this site with permission of Elsevier Ltd. Please see [url]http://www.thelancet.com/journals/laninf[/url] for further relevant comment.en
dc.subject.meshAnimalsen
dc.subject.meshAntimalarialsen
dc.subject.meshChilden
dc.subject.meshCost-Benefit Analysisen
dc.subject.meshDeveloping Countriesen
dc.subject.meshFemaleen
dc.subject.meshHumansen
dc.subject.meshMalariaen
dc.subject.meshMalaria Vaccinesen
dc.subject.meshMosquito Controlen
dc.subject.meshPregnancyen
dc.subject.meshPregnancy Complicationsen
dc.subject.meshResearchen
dc.titleMalaria: current status of control, diagnosis, treatment, and a proposed agenda for research and development.en
dc.typeArticleen
dc.contributor.departmentNorwegian Institute of Public Health, Norway. philippe.guerin@fhi.noen
dc.identifier.journalThe Lancet Infectious Diseasesen
refterms.dateFOA2019-03-04T11:55:23Z
html.description.abstractRolling back malaria is possible. Tools are available but they are not used. Several countries deploy, as their national malaria control treatment policy, drugs that are no longer effective. New and innovative methods of vector control, diagnosis, and treatment should be developed, and work towards development of new drugs and a vaccine should receive much greater support. But the pressing need, in the face of increasing global mortality and general lack of progress in malaria control, is research into the best methods of deploying and using existing approaches, particularly insecticide-treated mosquito nets, rapid methods of diagnosis, and artemisinin-based combination treatments. Evidence on these approaches should provide national governments and international donors with the cost-benefit information that would justify much-needed increases in global support for appropriate and effective malaria control.


Files in this item

Thumbnail
Name:
LID 2002 sept_Malaria R&D ...
Size:
267.3Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record